Clément Morgat

1.0k total citations
39 papers, 689 citations indexed

About

Clément Morgat is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Oncology. According to data from OpenAlex, Clément Morgat has authored 39 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Epidemiology and 15 papers in Oncology. Recurrent topics in Clément Morgat's work include Radiopharmaceutical Chemistry and Applications (24 papers), Neuroendocrine Tumor Research Advances (18 papers) and Neuropeptides and Animal Physiology (11 papers). Clément Morgat is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (24 papers), Neuroendocrine Tumor Research Advances (18 papers) and Neuropeptides and Animal Physiology (11 papers). Clément Morgat collaborates with scholars based in France, United States and Netherlands. Clément Morgat's co-authors include Elif Hindié, C. Champion, M. Quinto, Paolo Zanotti‐Fregonara, Philippe Fernandez, Delphine Vimont, Michèle Allard, Anil K. Mishra, Gaëtan MacGrogan and Valérie Velasco and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Clément Morgat

36 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clément Morgat France 14 416 281 238 187 127 39 689
Petra Kolenc Peitl Slovenia 20 526 1.3× 413 1.5× 110 0.5× 353 1.9× 80 0.6× 35 869
Irina Velikyan Sweden 15 736 1.8× 413 1.5× 237 1.0× 142 0.8× 47 0.4× 29 982
Ho Sze Chan Netherlands 14 474 1.1× 230 0.8× 177 0.7× 209 1.1× 19 0.1× 19 631
Michela Aurilio Italy 15 178 0.4× 195 0.7× 64 0.3× 119 0.6× 58 0.5× 23 560
Maarten Brom Netherlands 19 444 1.1× 349 1.2× 101 0.4× 395 2.1× 42 0.3× 58 1.4k
Stephan Maus Germany 20 851 2.0× 284 1.0× 719 3.0× 76 0.4× 40 0.3× 67 1.1k
Maria‐Luisa Tamma Switzerland 12 379 0.9× 356 1.3× 126 0.5× 284 1.5× 107 0.8× 14 641
Ute Hennrich Germany 8 717 1.7× 436 1.6× 474 2.0× 195 1.0× 19 0.1× 12 1.1k
Luigi Del Pozzo Switzerland 10 391 0.9× 354 1.3× 98 0.4× 325 1.7× 51 0.4× 17 629
Olivier Raguin France 16 227 0.5× 140 0.5× 169 0.7× 80 0.4× 41 0.3× 31 610

Countries citing papers authored by Clément Morgat

Since Specialization
Citations

This map shows the geographic impact of Clément Morgat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clément Morgat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clément Morgat more than expected).

Fields of papers citing papers by Clément Morgat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clément Morgat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clément Morgat. The network helps show where Clément Morgat may publish in the future.

Co-authorship network of co-authors of Clément Morgat

This figure shows the co-authorship network connecting the top 25 collaborators of Clément Morgat. A scholar is included among the top collaborators of Clément Morgat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clément Morgat. Clément Morgat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgat, Clément, Andrei Iagaru, & Elif Hindié. (2025). Gastrin-Releasing Peptide Receptor Imaging and Therapy in the Era of Personalized Medicine. Journal of Nuclear Medicine. 66(2). 207–208.
2.
Previti, Santo, Emmanuelle Rémond, Delphine Vimont, et al.. (2025). Design and Synthesis of 68Ga‐Labeled Peptide‐Based Heterodimers for Dual Targeting of NTS1 and GRPR. ChemMedChem. 20(9). e202400843–e202400843. 2 indexed citations
3.
Morgat, Clément, Heying Duan, Simone U. Dalm, et al.. (2025). A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry. Journal of Nuclear Medicine. 66(8). 1160–1167. 2 indexed citations
4.
Duan, Heying, et al.. (2025). GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy. Seminars in Nuclear Medicine. 55(6). 937–946. 1 indexed citations
5.
Previti, Santo, Emmanuelle Rémond, Delphine Vimont, et al.. (2024). Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics. RSC Medicinal Chemistry. 15(12). 4153–4158. 4 indexed citations
6.
Previti, Santo, Delphine Vimont, Imade Aït-Arsa, et al.. (2023). Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2. ACS Omega. 8(7). 6994–7004. 5 indexed citations
7.
Morgat, Clément, Michiel Van de Voorde, Stéphane Bodin, C. Champion, & Elif Hindié. (2023). Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb. Médecine Nucléaire. 47(6). 333–338. 4 indexed citations
8.
Cavelier, Florine, et al.. (2023). Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R. Cancers. 15(8). 2345–2345. 10 indexed citations
9.
Gonçalves, Victor, et al.. (2023). Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers. ACS Medicinal Chemistry Letters. 14(5). 636–644. 5 indexed citations
10.
Chennell, Philip, Bruno Pereira, R. Cueff, et al.. (2023). A proof of principle study using radiopharmaceuticals to quantify and localize container-content interactions in medical syringes. Scientific Reports. 13(1). 2721–2721.
11.
Lepreux, Sébastien, Nicole Barthe, Delphine Vimont, et al.. (2021). In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease. EJNMMI Research. 11(1). 45–45. 13 indexed citations
12.
Worm, Dennis J., Isabel D. Alves, Delphine Vimont, et al.. (2020). Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides. EJNMMI Research. 10(1). 16–16. 17 indexed citations
13.
Fanelli, Roberto, Santo Previti, Elif Hindié, et al.. (2020). Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS1-Positive Tumors Imaging. Bioconjugate Chemistry. 31(10). 2339–2349. 17 indexed citations
14.
Yacoub, Mokrane, Nicole Barthe, Delphine Vimont, et al.. (2019). Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples. EJNMMI Research. 9(1). 52–52. 25 indexed citations
15.
Morgat, Clément, Gaëtan MacGrogan, Véronique Brouste, et al.. (2017). Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors. Journal of Nuclear Medicine. 58(9). 1401–1407. 84 indexed citations
16.
Morgat, Clément, Fritz‐Line Vélayoudom‐Céphise, Martine Guyot, et al.. (2016). Evaluation of 68Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1. European Journal of Nuclear Medicine and Molecular Imaging. 43(7). 1258–1266. 33 indexed citations
17.
Champion, C., M. Quinto, Clément Morgat, Paolo Zanotti‐Fregonara, & Elif Hindié. (2016). Comparison between Three Promising ß-emitting Radionuclides, 67Cu, 47Sc and 161Tb, with Emphasis on Doses Delivered to Minimal Residual Disease. Theranostics. 6(10). 1611–1618. 66 indexed citations
18.
Morgat, Clément, Joachim Mazère, Philippe Fernandez, et al.. (2014). A phantom-based method to standardize dose-calibrators for new β + -emitters. Nuclear Medicine Communications. 36(2). 201–206. 3 indexed citations
19.
Morgat, Clément, Anil K. Mishra, Raunak Varshney, et al.. (2014). Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors. Journal of Nuclear Medicine. 55(10). 1650–1657. 83 indexed citations
20.
Morgat, Clément, Elif Hindié, Anil K. Mishra, Michèle Allard, & Philippe Fernandez. (2013). Gallium-68: Chemistry and Radiolabeled Peptides Exploring Different Oncogenic Pathways. Cancer Biotherapy and Radiopharmaceuticals. 28(2). 85–97. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Kolenc Peitl Breakdown of academic impact, for papers by Irina Velikyan Breakdown of academic impact, for papers by Ho Sze Chan Breakdown of academic impact, for papers by Michela Aurilio Breakdown of academic impact, for papers by Maarten Brom Breakdown of academic impact, for papers by Stephan Maus Breakdown of academic impact, for papers by Maria‐Luisa Tamma Breakdown of academic impact, for papers by Ute Hennrich Breakdown of academic impact, for papers by Luigi Del Pozzo Breakdown of academic impact, for papers by Olivier Raguin
Rankless by CCL
2026